ClusterOS Diagnostic Profile
Aberdeen LifeSciences
Aberdeen LifeSciences runs on 73 evidence items (Aberdeen LifeSciences UKRI grants: 128 grants, £84m total, 8 distinct lead or). The diagnostic resolves a Extraction-Intermediary configuration at HIGH confidence.
Incumbents extract value via intermediary relationships; intermediaries protect incumbent access; incumbent stability suppresses the disruption that would reduce extraction.
"If University of Aberdeen published annual data on: (1) PhD graduate destinations (Aberdeen vs. elsewhere), (2) spin-out equity ownership by location, (3) licensing revenue retention vs. distribution, it might reduce the system's ability to absorb success signals without local retention becoming visible as a...
Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.
A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.